When was Sava founded?

Sava was founded in 2021 and raised its 1st funding round 1 year after it was founded.

Where is Sava located?

Sava is headquartered in London, United Kingdom.

Who is the current CEO of Sava?

Rafael Michali and Renato Circi s of Sava. Rafael Michali has also founded 1 company.

Which legal entities is Sava associated with?

Sava is associated with SAVA TECHNOLOGIES LTD.

How many employees does Sava have?

As of Jul 31, 2026, the latest employee count at Sava is 158.

Is Sava a funded company?

Sava is a funded company, having raised a total of $38.5M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Dec 21, 2022.

How much is Sava worth?

The latest valuation of Sava is £***** as of Dec 20, 2024.

When was the latest funding round of Sava?

Sava's latest funding was a $***** Series A round on Jul 31, 2025, with participation from 8 investors.

Where does Sava rank among its competitors?

Sava ranks 15th amongst 973 active competitors, of which 224 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was Respiree, which secured an undisclosed amount in Feb, 2026.

Who are the top competitors of Sava?

Sava's top competitors include Insulet, Ceribell and HyperIce. Among them, Respiree secured the most recent funding round in February, 2026.

Sava - 2026 Company Profile, Team, Funding, Competitors & Financials

Sava is a series A company based in London (United Kingdom), founded in 2021 by Rafael Michali and Renato Circi. It operates as a Developer of minimally invasive, multi-molecule biosensors for continuous health monitoring. Sava has raised $38.5M in funding from investors like Balderton Capital, Exor and Pentland Ventures, with a current valuation of £*****. The company has 973 active competitors, including 224 funded and 57 that have exited. Its top competitors include companies like Insulet, Ceribell and HyperIce.

Company Details

Developer of minimally invasive, multi-molecule biosensors for continuous health monitoring. The biosensors gather data from just beneath the skin, providing real-time insights into various molecules. This technology enables continuous monitoring of health parameters, transitioning from episodic testing to continuous data streams accessible via a connected platform. The platform is designed for affordability and scalability, aiming to make advanced health monitoring accessible to a wider population. The sensors are engineered for comfort and accuracy, utilizing a multi-sensor architecture allowing for expansion beyond glucose monitoring to include other key biomarkers.

Key Metrics

Founded Year

2021

Location

London, United Kingdom

Stage

Series A

Total Funding

$38.5M in 3 rounds

Latest Funding Round

Series A, Jul 31, 2025, $*****

Post Money Valuation

£***** as on Dec 20, 2024

Investors

Balderton Capital & 13 more

Ranked

15^th among 973 active competitors

Employee Count

158 as on Jul 31, 2026

Similar Companies

Insulet & 996 more

View Sava's full profile

Sava is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
SAVA TECHNOLOGIES LTD CIN: 10500092 , United Kingdom, Active	Nov 28, 2016	-	34 (As on Mar 30, 2024)

Sava has raised a total funding of $38.5M over 3 rounds. Its first funding round was on Dec 21, 2022. Its latest funding round was a Series A round on Jul 31, 2025 for $*****. 8 investors participated in its latest round. Sava has 14 institutional investors.

Here is the list of recent funding rounds of Sava:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 31, 2025	1969390	Series A	8772753	9431846	9855938	2196944
Jun 21, 2024	5042213	Seed	8205175	9491568	2361622	7041001
Dec 21, 2022	5049692	Seed	4666309	2379503	3231043	8227559

Access funding benchmarks and valuations. Sign up today!

View details of Sava's funding rounds and investors

The founders of Sava are Rafael Michali and Renato Circi. Rafael Michali and Renato Circi are the CEOs of Sava.

Here are the details of Sava's key team members:

Rafael Michali: Co-Founder & Co-CEO of Sava and founder of 1 other company.
Contact Info: 1 email address
Renato Circi: Co-Founder & Co-CEO of Sava and founder of 1 other company.
Contact Info: 1 email address

View details of Sava's Founder profiles and Board Members

Sava's employee count trend

Sava has 158 employees as of Jul 26. Here is Sava's employee count trend over the years:

Uncover Sava's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Sava include Insulet, Ceribell and HyperIce. Here is the list of Top 10 competitors of Sava, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Insulet 2000, Boston (United States), Public	Manufacturer of wearable, tubeless insulin delivery systems for diabetes management	$120M	Federated Hermes, Piper Jaffray & 13 others	74/100
2nd	Ceribell 2014, Mountain View (United States), Public	EEG system for the diagnosis of seizures	$188M	The Rise Fund, Longitude Capital & 11 others	69/100
3rd	HyperIce 2011, Irvine (United States), Series C	Internet first brand offering smart devices for physical fitness	$52.5M	MainStreet Advisors, SC.Holdings & 38 others	69/100
4th	Endotronix 2007, East Peoria (United States), Acquired	Provider of device for Measurement of Hemodynamic parameters for heart failure maangement	$155M	Life Sciences Partners, Seroba Life Sciences ... & 14 others	65/100
5th	Biotricity 2014, San Francisco (United States), Public	Developer of medical remote monitoring solutions that help prevent and manage chronic diseases	-	SWK Holdings, National Research Council Canada ... & 2 others	63/100
6th	Athelas 2014, Mountain View (United States), Series A	Provider of smart solutions for monitoring heart rate, weight, and blood pressure	$136M	Tribe Capital, Sequoia Capital & 19 others	61/100
7th	Biobeat 2014, Petah Tikva (Israel), Series B	Body vitals monitoring solution	$51M	Orbimed, Ally Bridge Group & 5 others	61/100
8th	Somatix 2015, New York City (United States), Acquired	Provider of an AI-based remote health monitoring tool	$21.2M	Digitalis Ventures, New York Digital Health ... & 5 others	61/100
9th	Respiree 2018, Singapore (Singapore), Series A	Provider of AI and sensors-based post care solutions	$15M	She1K, Clavystbio & 20 others	60/100
10th	Neteera 2014, Jerusalem (Israel), Series B	Provider of a contactless remote patient monitoring platform	$28.2M	Aescuvest, Foxconn Electronics & 9 others	60/100
15th	Sava 2021, London (United Kingdom), Series A	Developer of minimally invasive, multi-molecule biosensors for continuous health monitoring	$38.5M	JamJar Investments, Balderton Capital & 12 others	56/100